DHAI - DIH Holding US Market Capitalization-to-Revenue Ratio

Corporate company logo of DIH Holding US (DHAI)

DIH Holding US, Inc. (DHAI) generates revenue by supplying robotics for patient rehabilitation to clinics worldwide. Analyzing the historical P/S dynamics on GURU.Markets, we note that the current parameter stands at 0.00. However, logistical disruptions in Asia remain vulnerable to sanctions, while high debt levels and a decline in government procurement across the US and Europe hinder the achievement of operating profit.

DHAI: DIH Holding US Inc. Price-to-Revenue Ratio 02/19/2025 - 11/08/2025

Analytical breakdowns for DIH Holding (DHAI)

- share price and consensus valuation forecast:
- market capitalization statistics:
General company analysis:DHAI, DIH Holding US
Product sample of dih.com

The scale dynamics of DIH Holding US, Inc. (DHAI) are reflected through the price-to-sales ratio, which allows for an assessment of the business's market value relative to its annual revenue. This metric measures the extent to which the asset's price is inflated over actual earnings, which is critical amid growing competition from low-cost mechanical alternatives when the market overvalues the technological advantage of robotics over simple solutions.

Competitors of DIH Holding US, Inc.

HCA (HCA Healthcare) - Market Capitalization-to-Revenue Ratio|Tenet Healthcare Corporation - Market Cap to Revenue|Fresenius Medical (FMS) - Price to Sales|Solventum Corp - P/S Multiple|Price-to-Sales Ratio EHC|Universal Health Services (UHS) - Price-to-Revenue Ratio|DaVita - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners, Inc.)|PINC (Premier, Inc.) - Market Capitalization-to-Revenue Ratio|National Vision - Market Cap to Revenue|Price-to-Revenue Coefficient Progyny Inc (PGNY)|Ardent Health - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corp SEM|ASTH: P/S Multiple|Market Cap to Revenue Ratio MD|USPH (US Physical Therapy Inc) - P/S Multiple|PNTG: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Organogenesis Corp (ORGO)|NUTX (Nutex Health Corp) - Market Capitalization-to-Revenue Ratio|P/S Multiple AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Price to Sales|EOLS - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Market Cap to Revenue|Market Cap to Revenue Ratio MDWD|Price-to-Revenue Ratio biote Corp.|Price to Sales thejoint.com JYNT|P/S Multiple DCGO|Market Cap to Revenue P3 Health PIII|P/S Multiple GANX (Gain Therapeutics Inc.)|P/S Multiple EUDA Health Holdings Limited EUDA|baselmedical.com - P/S Multiple|CLGN: Price-to-Revenue Ratio|Cuprina Holdings (Cayman) Ltd. (CUPR) - Price-to-Revenue Ratio|Market Cap to Revenue Concord Medical|AMS (American Shared Hospital Services Inc) - P/S Multiple|MEDIROM Corp (MRM) - Price-to-Revenue Coefficient|P/S Multiple ALBT|Longevity Health Holdings - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NewGenIvf Group Ltd NIVF|ATIP (atipt.com) - Price-to-Sales Ratio|CMAX: Market Cap to Revenue|Price to Sales Kindly Health|ModivCare (MODV) - Price-to-Revenue Ratio|NVOS (novointegrated.com) - Price-to-Revenue Ratio|SSY (SunLink Health Systems Inc.) - P/S Multiple|BACK (IMAC Holdings Inc) - Market Cap to Sales Volume